Coalition for Epidemic Preparedness Innovations

Other · Oslo, Norway

Founded in 2017, Coalition for Epidemic Preparedness Innovations is an impact investor headquartered in Oslo, Norway. 13 portfolio companies are on record.

AUM
—
Portfolio companies
13
Recorded deals
30
11 in last 12M
Last investment
—

Coalition for Epidemic Preparedness Innovations key facts

  • Coalition for Epidemic Preparedness Innovations is a other based in Oslo, Norway with 13 tracked portfolio companies.
  • Notable positions include DNA Script, Akagera Medicines, Centivax.

About Coalition for Epidemic Preparedness Innovations

Founded in 2017, Coalition for Epidemic Preparedness Innovations is an impact investor headquartered in Oslo, Norway. The firm provides funding, research and development in enabling science and vaccine technology and manufacturing and supply chains.

Coalition for Epidemic Preparedness Innovations portfolio at a glance

13 portfolio companies are on record for Coalition for Epidemic Preparedness Innovations, including DNA Script, Akagera Medicines and Centivax.

8 of the 13 carry a recorded valuation.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 13 recorded positions
  • ·Watchlist + alerts for Coalition for Epidemic Preparedness Innovations's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

13 companies · priced for members
CompanyValuationRole
DNA Script▮▮
Akagera Medicines▮▮
Centivax▮▮
+ 10 more companies · all 13, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Frequently asked about Coalition for Epidemic Preparedness Innovations

What companies does Coalition for Epidemic Preparedness Innovations invest in?
Coalition for Epidemic Preparedness Innovations has 13 recorded portfolio companies, including DNA Script, Akagera Medicines, Centivax.